Eternygen presents data demonstrating INDY inhibition as novel therapeutic option in NASH

February 10, 2020
Study to be presented at 3rd Global NASH Congress in London, U.K., February 10, 11. Data shows, for the first time, that INDY inhibition attenuates diet-induced NASH and mINDY inhibitors may be a novel therapeutic option. In a murine NASH model, a small molecule INDY inhibitor reduced transaminases, hepatic injury, steatosis and inflammation, and improved glucose metabolism and body composition compared to vehicle-treated mice Read more
Reading level: Grade 12
EurekAlert!, the online, global news service operated by AAAS, the science society
Please Give Us Feedback!

Why are you reading this article? (check all that apply)







How do you feel about science?







Send Feedback
Free science fair projects.